Anticancer Effects of Cyclocarya paliurus Polysaccharide (CPP) on Thyroid Carcinoma In Vitro and In Vivo

He, Zhiwei; Lv, Fangfang; Gan, Yueli; Gu, Jing; Que, Ting

doi:https://doi.org/10.1155/2018/2768120

International Journal of Polymer Science

On this page

Abstract Introduction Materials and Methods Results Discussion Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Polysaccharides for Biomedical Applications

View this Special Issue

Research Article | Open Access

Volume 2018 | Article ID 2768120 | https://doi.org/10.1155/2018/2768120

Anticancer Effects of Cyclocarya paliurus Polysaccharide (CPP) on Thyroid Carcinoma In Vitro and In Vivo

Zhiwei He,¹Fangfang Lv,²Yueli Gan,¹Jing Gu,¹and Ting Que¹

Guest Editor: Jianxun Ding

Received14 Sept 2018

Revised19 Oct 2018

Accepted23 Oct 2018

Published27 Dec 2018

Abstract

In this study, we explored the role and mechanisms of Cyclocarya paliurus polysaccharide on cell apoptosis in thyroid cancer (TC) cells. The apoptosis of thyroid cancer cells in vitro and tumor tissues in vivo induced by Cyclocarya paliurus polysaccharide was determined by MTT assay and flow cytometric assay. The downstream molecules including phosphop-protein kinase B (p-Akt), Akt, B-cell lymphoma 2 (Bcl-2), and Bcl-2-associated X protein (Bax) in tumor tissue were evaluated by western blotting. MTT and flow cytometry assay in vitro revealed Cyclocarya paliurus polysaccharide-induced apoptosis of thyroid cancer cell line in a manner of time-dependent and dose-dependent. In vivo assay showed 50 mg/kg and 100 mg/kg Cyclocarya paliurus polysaccharide significantly suppressed the proliferation of thyroid cancer in mice. Western blotting showed downregulation of p-Akt, Akt, and Bcl-2 and upregulation of Bax. These results suggest that Cyclocarya paliurus polysaccharide may enhance thyroid cancer cell apoptosis by suppressing the activation of p-Akt, Akt, and Bcl-2 and activating Bax, which provide a novel use of CPP as a thyroid cancer treatment.

1. Introduction

Plant polysaccharides are natural polymeric macromolecules generally composed of more than ten monosaccharide units joined by glycosidic bonds, playing an important role in life-support activities. Biological activities of polysaccharides have been broadly investigated since the 1940s. Plant polysaccharides have biological effects such as immunoregulation, anticancer, antiaging, serum glucose-depressing, and lipid-depressing [1–5]. And recently a growing number of studies have demonstrated the significant advantages of polysaccharides in the prevention and treatment of critical or chronic diseases in human such as cancers, cardiovascular diseases, and diabetes [6–8].

Moreover, there are some limitations of present therapy against thyroid cancer. Patients with different types of thyroid cancer exhibited poor or modest response to traditional chemotherapy [9]. Till date, present goals are to identify novel agents to improve response and progression-free survival. Researches show that most of the plant polysaccharides perform anticancer effect through strengthening immune function against cancer cells by regulating the levels of cytokines secreted by the host cells [10]. On the other hand, cytotoxic polysaccharides possess tumor cytotoxicity, which showed direct interactions with cancer cells [11]. However, the effects of Cyclocarya paliurus polysaccharide on thyroid carcinoma are still largely unknown.

In the past decade, progress has been made to understand the molecular mechanisms of thyroid cancer. The best represented advances in genetic and epigenetic events occurring in thyroid cancer was Akt, which was reported to be involved in several major pathways [12]. Hyperactivation of Akt promotes cell transformation and tumorigenesis in multiple tumors. In addition, Bcl-2 family of proteins is a major intracellular modulator of apoptotic signaling, which exist in normal and neoplastic thyroid tissue [13]. It was reported that overexpression of Bcl-2 in thyroid carcinoma cells increased oncogenic addiction of cells. Another molecule influencing the apoptotic balance in cancer tissues is Bax. It has been assumed that the ratio of Bcl-2/Bax determines cell death [14].

In the present study, we investigate the mechanism by which polysaccharides isolated by Cyclocarya paliurus and determine its possible anticancer properties. Furthermore, we established a mouse model to reveal the underlying mechanism of anticancer effects in vitro and in vivo.

2. Materials and Methods

2.1. Reagents

Plant materials and preparation of C. paliurus polysaccharides were obtained previously [15]. The leaves of C. paliurus were collected from a planting base in Enshi, Hubei Province, China. Sugar content was measured by the phenol-sulfuric acid colorimetric method with D-glucose as a standard at 490 nm. Phospho-Akt1 (S246) polyclonal antibody was purchased from R&D. AKT antibody was purchased from Rockland. Bcl-2 monoclonal antibody, Bax polyclonal antibody, GAPDH, and HRP Mouse mAb were purchased from MultiSciences.

2.2. Cell Lines

Thyroid carcinoma cell lines (FRO, ARO, 8505C, SW579, K1, FTC133, and BCPAP) were purchased from FuHeng Cell Center, Shanghai, China. The cells were cultured in RPMI-1640 medium (Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS), 100 units/mL penicillin (Sigma-Aldrich, St. Louis, USA), and 0.1 mg/mL streptomycin (Sigma-Aldrich, St. Louis, USA). All cells were maintained in a humidified incubator containing 5% humidified CO₂ at 37°C.

2.3. Animals

All animal procedures were approved by the Animal Care and Use Committee of the institution in compliance with the Guide for the Care and Use of Laboratory Animals. Forty male BALB/c nude mice (18–20 g, 5–6 week age) were obtained from a commercial vendor (Beijing Huafukang Bioscience Co. Inc., Beijing, China, permit number: SCXK-JING 2014-0004). All the mice were housed under pathogen-free conditions in accordance with laboratory animal care and allowed free access to sterilized food and water. After FRO cells were harvested, tumor inoculation was performed in the right foreleg (5 × 10⁶ cells/mice). Mice in NC and TC groups were orally administered with distilled water. Tumor volume was quantified with caliper, using the formula as follows: tumor volume = 0.5 × length × width2. At the time of sacrificing, tumor tissues were quickly dissected and weighed.

2.4. MTT Assay

The inhibition effect of CPP on seven human thyroid carcinoma cell lines (FRO, ARO, 8505C, SW579, K1, FTC133, and BCPAP cells) was measured by MTT assay in vitro. Briefly, the thyroid carcinoma cells (2 × 10⁴ cells/well) were incubated in 96-well plates with 0.2 mL cell culture medium at 37°C. Cells were allowed to adhere for 24 h, then were incubated in the culture containing CPP with different concentration (0, 30, and 100 μg/mL) for extra 48 h. After the exposure to CPP, 20 μL of MTT assay reagent were added to each well, and the cells continued to be cultured for 1 h. After the medium was removed, 50 μL of DMSO were added to each well and were incubated for 10 min. The absorbance value of the plate was read at 570 nm by the microplate reader. The inhibition rate was calculated as follows: growth inhibitory rate (%) = (1-absorbance of the experimental group/absorbance of the blank control group) × 100%.

2.5. Flow Cytometry

Flow cytometry was performed to identify cell apoptosis by using Annexin V-FITC/PI kit (Qiangen, China), followed by the manufacturer’s instructions. After incubation with Cyclocarya paliurus polysaccharide, cells were collected and washed with phosphate-buffered saline (PBS) and stained with Annexin V-FITC/PI. Binding buffer (150 μL) and Annexin-V-FITC (5 μL) were added into each tube and incubated at room temperature for 15 min. Subsequently, binding buffer (100 μL) and PI (5 μL) were also added and incubated for 5 min. At least 10000 cells in each sample were acquired by flow cytometry FC500 (Beckman Coulter, USA) and analyzed with CXP analysis software 2.2 (Beckman Coulter, Inc.).

2.6. Western Blotting

Tumor tissues isolated from mice and collected by surgical manipulation were quickly frozen in liquid nitrogen and sliced to a thickness of 8 μm using a microtome (Leica CM1900, Berlin, Germany). Total protein was extracted from cells and tumor tissues using ice-cold RIPA lysis buffer (Beyotime, Shanghai, China). The concentration was calculated by a bicinchoninic acid (BCA) assay kit (Beyotime, Shanghai, China). 30 μg of proteins were separated using 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, Bio-Rad, CA, USA) and transferred to a polyvinylidene difluoride (PVDF) membrane. After blocked with 5% nonfat milk for 1 h, samples were incubated with primary antibodies against p-Akt (1 : 1000) polyclonal antibody, Akt (1 : 1000), Bcl-2 (1 : 1000), Bax (1 : 1000), and GAPDH (1 : 1000) at 4°C overnight. After washed with Tris-buffered saline/Tween 20 (TBST), the membrane was incubated with HRP-conjugated secondary antibody (1 : 5000) for 1 h at room temperature. Washed three times with TBST, the protein was detected with an enhanced chemiluminescence (ESL) western blot detection system (Millipore, Bedford, MA, USA). GAPDH was considered to be reflective of the relative protein expression.

2.7. Statistical Analysis

All values were expressed as mean ± standard deviation (SD). All experimental data were analyzed using SPSS 21.0 software (IBM Corp., USA). Comparisons between groups were conducted using a paired t-test. Comparisons between two groups were performed using an independent sample t-test. Comparisons among multiple groups were assessed by one-way analysis of variance (ANOVA). Enumeration data were expressed as percentage and analyzed by chi-square test. A value of was indicative of statistical significance.

3. Results

3.1. Extraction and Content Determination of CPP

In this study, we isolated polysaccharide from C. paliurus by water extraction and ethanol precipitation. To confirm purity of polysaccharide, we further analyzed the sugar contents by the phenol-sulfuric acid colorimetric method. The purity of polysaccharide was determined to be 89.5%.

3.2. Growth Inhibitory Effect of CPP on Thyroid Carcinoma Cell Lines

The growth inhibitory rate of CPP with different levels on seven human thyroid carcinoma cell lines was evaluated to characterize the antithyroid cancer effect of CPP and screen for the cell line with the most effective inhibition induced by CPP. Cell viability of cell lines was analyzed by MTT assay. The cell growth was significantly inhibited in all of the seven thyroid carcinoma cell lines after incubated with 30 and 100 μg/mL of CPP (, Figure 1(a)). And the effect of CPP in 100 μg/mL on growth inhibition of thyroid carcinoma cells was more significant than that in 30 μg/mL.

(a)

(b)

Figure 1

Inhibitory rate of thyroid carcinoma cell lines induced by CPP. (a) Inhibitory rates of a panel of thyroid carcinoma cell lines (FRO, ARO, 8505C, SW579, K1, FTC133, and BCPAP) that treated with CPP (0 μg/mL, 30 μg/mL, and 100 μg/mL) are presented. (b) Inhibitory rates of FRO cells treated with CPP for 24 h, 48 h, and 72 h. The results were expressed as a percentage of the control, which was set at 100%. Data were presented as mean ± SD. compared with control. compared with control. compared with control. All experiments were performed triplicate.

The inhibitory rate on anaplastic thyroid carcinoma-derived FRO cells was approximately 50% at the CPP concentration of 30 μg/mL, only slightly lower than that on differentiated thyroid carcinoma-derived BCPAP cells (%). However, the inhibitory rate on FRO was up to 90% at the concentration of 100 μg/mL, which is higher than all other thyroid carcinoma cell lines tested including BCPAP cells. Therefore, anaplastic thyroid carcinoma-derived FRO cells were selected and used for further investigation.

We further investigated the effect of 100 μg/mL CPP on FRO for 24 h, 48 h, and 72 h. As shown in Figure 1(b), FRO cells treated for 72 h presented higher inhibitory effect, when compared to those of 48 h and 24 h, with no significance. These results indicating that the inhibitory effect of CPP possessed dose-dependent and time-dependent.

3.3. Apoptosis Assay of Tumor Tissues Induced by CPP

Mice treated with PBS were served as control. As shown in Figure 2(a), 50 mg/kg and 100 mg/kg for 30 days significantly decreased the tumor weight, when compared with PBS group. During the period of dosing with CPP, tumor volume in mice increased (Figure 2(b)). Annexin V-FITC double staining was performed to detect tumor cell apoptosis in tumor tissues of mice (Figures 2(c)–2(f)). Treatment of 50 mg/kg and 100 mg/kg CPP resulted in a significant apoptosis of tumor cells in mice by 17.7 ± 2.3% and 21.3 ± 2.6% ().

(a)

(b)

(c)

(d)

(e)

(f)

3.4. Expressions of p-Akt, Akt, Bcl-2, and Bax Proteins in Tumor Tissues Regulated by CPP

Protein (Figure 3) expressions of p-Akt, Akt, Bcl-2, and Bax after the mice were sacrificed were evaluated in all three treatment groups. 50 mg/kg and 100 mg/kg treatment of CPP significantly raised p-Akt/Akt protein expressions by 77.6% and 48.1% (Figure 3(b), ). The Bcl-2 protein expressions decreased by 78.5% and 69.2% (Figure 3(c), ). The Bax protein expression had elevated to 1.67-fold and 2.23-fold (Figure 3(d), ). CPP had a strong promoting effect on apoptosis, indicating functional involvement of p-Akt, Akt, Bcl-2, and Bax in apoptosis induced by CPP.

(a)

(b)

(c)

(d)

4. Discussion

The infiltration of inflammatory cells usually could be found in thyroid cancer, including lymphocytes, macrophages, and mast cells. Although the role of these cells in cancer and function mechanism is not entirely clear, most of the experiments show that these cells promote the development of tumor. Therefore, inflammatory molecules can be a potential thyroid cancer treatment target, while immunotherapy gradually become the focus in the treatment of thyroid cancer in recent years. As reported, qing qian liu polysaccharide has been proven to have the function of immune regulation and can inhibit the release of IL-6 and TNF-β by macrophages stimulated by LPS [16]. Cyclocarya paliurus polysaccharide is a kind of natural plant polysaccharide extracted from Cyclocarya paliurus. Because of its special physical and chemical effects and small side effects, it has become a potential active compound. Currently, studies on the anticancer capacities of polysaccharides focused on the apoptotic effect. The cytotoxicity of the components from Inonotus obliquus was identified in human prostatic carcinoma cell PC3 and breast carcinoma MCF-7 cell [17, 18]. In vivo and in vitro studies have confirmed polysaccharides from P. However, the signal pathways involved in the apoptosis of cancer cells are complex, and the signal mechanisms of apoptosis are often different in different tumor cell types.

In this study, we isolated polysaccharide from C. paliurus by water extraction and ethanol precipitation. To confirm the contents of polysaccharide, we further measured the sugar contents by the phenol-sulfuric acid colorimetric method. The total content of polysaccharide was determined to be 89.5%. Previous study showed that CPP exerts antiproliferation effect on various tumor cell lines [17–19]. We observed CPP inhibited cell proliferation and induced apoptosis in a pair of thyroid carcinoma cell lines including FRO, ARO, 8505C, SW579, K1, FTC133, and BCPAP. Also, a similar trend was observed in a mouse model. Tumor weight of mice was significantly reduced after treated with CPP.

In our previous study, we explored the potential mechanism of apoptosis of human colon cancer cell HT29 induced by CPP. MTT colorimetric assay was used to detect that Cyclocarya paliurus polysaccharides could significantly inhibit the proliferation of human colon cancer cell HT29. Our previous results suggested that apoptosis induction may be the main mechanism of antitumor effect of CPP. The results of flow cytometry showed that the polysaccharide could induce apoptosis of human colon cancer cell line HT29, and the typical morphological characteristics of apoptotic cells could be observed. As a major strategy for cancer therapeutics, Annexin V/PI staining was conducted to determine whether the cytotoxic effect was related to the apoptotic process. We found that after dosing with CPP, the percentages of early and late apoptotic tumor cells were markedly increased. All these data indicated that CPP induced apoptosis in thyroid tumor.

To understand the possible molecular mechanisms of thyroid cancer cytotoxicity, we explored the related mechanisms. The PI3K/AKT pathway is the most studied frequently mutated network in human cancer [20]. Overactivation of this protein is associated with tumor growth, invasion, and drug resistance. Our results confirmed that CPP markedly downregulated p-Akt and Akt protein levels. Considering p-Akt is the active form of Akt, our data suggested that CPP inhibited active form of Akt directly and indirectly.

In general, cellular life and death are regulated by the Bcl-2 family proteins and the balance between Bcl-2 and Bax. Abnormal expression of Bcl-2 and Bax contribute to tumor survival and growth. Furthermore, Bcl-2 and Bax regulate cell apoptosis process in an independent way [21]. Mitochondrial membrane associated Bcl-2 modulates the expression of some apoptotic factors that usually sequestered in the mitochondrial intermembrane space. Bax plays an essential role in rescuing the sensitivity of apoptosis [22]. If Bcl-2 failed to exert the antiapoptosis role, Bax will form a channel in the mitochondrial outer membrane that facilitate apoptosis [23]. Here, we revealed that CPP markedly reduced Bcl-2 protein levels and elevated Bax protein levels.

To summarize, CPP has a remarkable inhibition in thyroid tumor growth both in vitro and in vivo, making it of significance in studies. CPP exerts an anticancer effect on thyroid cancer cells through p-Akt, Akt, Bcl-2, and Bax pathways. Our data suggest a potential strategy as a promising therapy for thyroid cancer.

Data Availability

The data used to support the findings of this study are included within the article.

Ethical Approval

Approval for the present study was obtained by the Ethics Committee of the Shanghai Post and Telecommunication Hospital (Shanghai, China).

All patients admitted to the study provided informed consent for their participation of the present study and the publication of this data.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

TQ was responsible for the study conception and design and revised the manuscript; ZH and FL performed the experiments and drafted the manuscript; YG and JG analyzed the data. All authors read and approved the final manuscript.

Acknowledgments

This work was funded by the Health and Family Planning Commission Foundation of Shanghai (No. 201540289).

References

M. Sundberg-Kövamees, J. Grunewald, and J. Wahlström, “Immune cell activation and cytokine release after stimulation of whole blood with pneumococcal C-polysaccharide and capsular polysaccharides,” International Journal of Infectious Diseases, vol. 52, pp. 1–8, 2016.
View at: Publisher Site | Google Scholar
J. Chen, J. Ding, W. Xu et al., “Receptor and microenvironment dual-recognizable nanogel for targeted chemotherapy of highly metastatic malignancy,” Nano Letters, vol. 17, no. 7, pp. 4526–4533, 2017.
View at: Publisher Site | Google Scholar
Y. Zhang, T. Lv, M. Li et al., “Anti-aging effect of polysaccharide from Bletilla striata on nematode Caenorhabditis elegans,” Pharmacognosy Magazine, vol. 11, no. 43, pp. 449–454, 2015.
View at: Publisher Site | Google Scholar
Y. G. Li, D. F. Ji, S. Zhong, Z. Q. Lv, and T. B. Lin, “Cooperative anti-diabetic effects of deoxynojirimycin-polysaccharide by inhibiting glucose absorption and modulating glucose metabolism in streptozotocin-induced diabetic mice,” PLoS One, vol. 8, no. 6, article e65892, 2013.
View at: Publisher Site | Google Scholar
D. Qin, X. Yang, S. Gao, J. Yao, and D. J. McClements, “Influence of hydrocolloids (dietary fibers) on lipid digestion of protein-stabilized emulsions: comparison of neutral, anionic, and cationic polysaccharides,” Journal of Food Science, vol. 81, no. 7, pp. C1636–C1645, 2016.
View at: Publisher Site | Google Scholar
Y. Jiang, Y. Chang, Y. Liu et al., “Overview of Ganoderma sinense polysaccharide–an adjunctive drug used during concurrent chemo/radiation therapy for cancer treatment in China,” Biomedicine & Pharmacotherapy, vol. 96, pp. 865–870, 2017.
View at: Publisher Site | Google Scholar
J. Zhang, S. Fan, Y. Mao et al., “Cardiovascular protective effect of polysaccharide from Ophiopogon japonicus in diabetic rats,” International Journal of Biological Macromolecules, vol. 82, pp. 505–513, 2016.
View at: Publisher Site | Google Scholar
D. Li, J. Han, J. Ding, L. Chen, and X. Chen, “Acid-sensitive dextran prodrug: a higher molecular weight makes a better efficacy,” Carbohydrate Polymers, vol. 161, pp. 33–41, 2017.
View at: Publisher Site | Google Scholar
V. Bernet and R. Smallridge, “New therapeutic options for advanced forms of thyroid cancer,” Expert Opinion on Emerging Drugs, vol. 19, no. 2, pp. 225–241, 2014.
View at: Publisher Site | Google Scholar
N. Wang, J. Yang, J. Lu et al., “A polysaccharide from Salvia miltiorrhiza Bunge improves immune function in gastric cancer rats,” Carbohydrate Polymers, vol. 111, pp. 47–55, 2014.
View at: Publisher Site | Google Scholar
C. Caro and D. Pozo, “Polysaccharide colloids as smart vehicles in cancer therapy,” Current Pharmaceutical Design, vol. 21, no. 33, pp. 4822–4836, 2015.
View at: Publisher Site | Google Scholar
M. Xing, B. R. Haugen, and M. Schlumberger, “Progress in molecular-based management of differentiated thyroid cancer,” The Lancet, vol. 381, no. 9871, pp. 1058–1069, 2013.
View at: Publisher Site | Google Scholar
C. S. Mitsiades, P. Hayden, V. Kotoula et al., “Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 12, pp. 4845–4852, 2007.
View at: Publisher Site | Google Scholar
Z.-g. Zhang, J. Zou, Y. Huang, and L. Wu, “Kinetin inhibits proliferation of hepatic stellate cells by interrupting cell cycle and induces apoptosis by down-regulating ratio of Bcl-2/Bax,” Journal of Huazhong University of Science and Technology [Medical Sciences], vol. 35, no. 5, pp. 672–678, 2015.
View at: Publisher Site | Google Scholar
J. Y. Yin, S. P. Nie, C. Zhou, Y. Wan, and M. Y. Xie, “Chemical characteristics and antioxidant activities of polysaccharide purified from the seeds of Plantago asiatica L,” Journal of the Science of Food and Agriculture, vol. 90, no. 2, pp. 210–217, 2010.
View at: Publisher Site | Google Scholar
Z. Wang, J. Xie, Y. Yang et al., “Sulfated Cyclocarya paliurus polysaccharides markedly attenuates inflammation and oxidative damage in lipopolysaccharide-treated macrophage cells and mice,” Scientific Reports, vol. 7, no. 1, 2017.
View at: Publisher Site | Google Scholar
H. Zhang, Y. Jing, and G. Wu, “Inhibitory effects of crude polysaccharides from Semen vaccariae on benign prostatic hyperplasia in mice,” Journal of Ethnopharmacology, vol. 145, no. 2, pp. 667–669, 2013.
View at: Publisher Site | Google Scholar
Z. Luo, H. Zeng, Y. Ye et al., “Safflower polysaccharide inhibits the proliferation and metastasis of MCF-7 breast cancer cell,” Molecular Medicine Reports, vol. 11, no. 6, pp. 4611–4616, 2015.
View at: Publisher Site | Google Scholar
T. Shinbo, S. Fushida, T. Tsukada et al., “Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway,” Oncology Reports, vol. 33, no. 2, pp. 553–558, 2015.
View at: Publisher Site | Google Scholar
B. Han, P. Jiang, Z. Li et al., “Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway,” Phytomedicine, vol. 48, pp. 152–160, 2018.
View at: Publisher Site | Google Scholar
S. Gaumer, I. Guénal, S. Brun, L. Théodore, and B. Mignotte, “Bcl-2 and Bax mammalian regulators of apoptosis are functional in Drosophila,” Cell Death & Differentiation, vol. 7, no. 9, pp. 804–814, 2000.
View at: Publisher Site | Google Scholar
S. Zhu, T. Li, J. Tan et al., “Bax is essential for death receptor-mediated apoptosis in human colon cancer cells,” Cancer Biotherapy & Radiopharmaceuticals, vol. 27, no. 9, pp. 577–581, 2012.
View at: Publisher Site | Google Scholar
T. Moldoveanu, A. V. Follis, R. W. Kriwacki, and D. R. Green, “Many players in BCL-2 family affairs,” Trends in Biochemical Sciences, vol. 39, no. 3, pp. 101–111, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2018 Zhiwei He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1407

Downloads

944

Citations